U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
105781105781Covering of the Abdominal Wall in Laparotomies: Differences in Surgical Site Infections Between an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven Swabs at Technische Universität MünchenCompletedNo Results AvailableComparing the Number of Surgical Site Infections:|Covering of the Abdominal Wall in Laparotomies With an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven|SwabsProcedure: Intervention Arm 1: Covering with approved abdominal 3M™ Steri-Drape™ Wound Edge Protector Intervention Arm 2: Covering with standard woven swabshttps://ClinicalTrials.gov/show/NCT01181206
105782105782Vitamin D for Treatment of Glioblastoma MultiformeRecruitingNo Results AvailableGlioblastoma MultiformeOther: Surgery|Radiation: Radiotherapy to tumour bed and/or residual tumour|Drug: Temozolomide|Drug: Vitamin D3https://ClinicalTrials.gov/show/NCT01181193
105783105783The Effect of Fluids Consumption on Balance and Gait Function in Old AdultsCompletedNo Results AvailableAging|DehydrationDietary Supplement: water consumptionhttps://ClinicalTrials.gov/show/NCT01181180
105784105784A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedHas ResultsPrevention|Venous ThromboembolismDrug: edoxaban|Drug: enoxaparin sodiumhttps://ClinicalTrials.gov/show/NCT01181167
105785105785Rituximab in Auto-Immune Hemolytic AnemiaActive, not recruitingNo Results AvailableWarm Autoimmune Hemolytic AnemiaDrug: rituximab (Mabthera®)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01181154
105786105786Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedHas ResultsVenous ThromboembolismDrug: DU-176b (edoxaban)|Drug: Enoxaparin sodium 20mghttps://ClinicalTrials.gov/show/NCT01181141
105787105787Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia ACompletedHas ResultsSevere Hemophilia ADrug: Factor VIII (rFVIIIFc)|Drug: Advate®https://ClinicalTrials.gov/show/NCT01181128
105788105788Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)CompletedNo Results AvailableMultiple SclerosisDrug: Avonexhttps://ClinicalTrials.gov/show/NCT01181115
105789105789A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedHas ResultsVenous ThromboembolismDrug: edoxaban|Drug: enoxaparin sodiumhttps://ClinicalTrials.gov/show/NCT01181102
105790105790Dose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS)WithdrawnNo Results AvailableSecondary Progressive Multiple SclerosisBiological: Placebo|Biological: Baminercepthttps://ClinicalTrials.gov/show/NCT01181089
105791105791Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of LifeRecruitingNo Results AvailableEffect of Individualized Nutrition on Quality of LifeDietary Supplement: Individualized Nutritionhttps://ClinicalTrials.gov/show/NCT01181076
105792105792Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder InhalersCompletedNo Results AvailableAsthmaDrug: Budesonide/formoterol 320/9 μg and 400/12 μg inhalershttps://ClinicalTrials.gov/show/NCT01181063
105793105793Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)CompletedHas ResultsInflammation|Rheumatoid ArthritisDrug: NNC0142-0002|Drug: placebohttps://ClinicalTrials.gov/show/NCT01181050
105794105794Bipolar H.A Versus Trochanteric Antegrade Nail for Treatment of Displaced Subcapital Femoral FracturesRecruitingNo Results AvailableDisplaced Subcapital Femoral Fracturehttps://ClinicalTrials.gov/show/NCT01181037
105795105795A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1CompletedNo Results AvailableHepatitis C, Chronic, Healthy VolunteerDrug: Placebo|Drug: RO5303253|Drug: RO5303253|Drug: RO5303253https://ClinicalTrials.gov/show/NCT01181024
105796105796Telmisartan, Amlodipine and Combination in Healthy SubjectsCompletedHas ResultsHealthyDrug: amlodipine/telmisartan/combinationhttps://ClinicalTrials.gov/show/NCT01181011
105797105797Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens UsersCompletedHas ResultsAstigmatismDevice: Senofilcon A Toric (AOfA)|Device: Etafilcon A Toric (1DAMfA)https://ClinicalTrials.gov/show/NCT01180998
105798105798Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact LensCompletedHas ResultsMyopiaDevice: galyfilcon A prototype lens|Device: comfilcon Ahttps://ClinicalTrials.gov/show/NCT01180985
105799105799Effects of Environmental Opportunities and Barriers on Physical Activity, Fitness, and Health in Hispanic Children in WisconsinCompletedNo Results AvailableObesity, Diabetes, Nutrition, Physical Healthhttps://ClinicalTrials.gov/show/NCT01180972
105800105800Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line TherapyActive, not recruitingNo Results AvailableLiver CancerDrug: Bevacizumab|Drug: Erlotinibhttps://ClinicalTrials.gov/show/NCT01180959
105801105801Vitamin D Deficiency in Adolescent GirlsCompletedNo Results AvailableHealthy|Vitamin D DeficiencyDietary Supplement: ergocalciferol|Other: placebo pillhttps://ClinicalTrials.gov/show/NCT01180946
105802105802Fish Oil and Folate Supplementation During PregnancyCompletedNo Results AvailablePerinatal DHA and Folate Status|Neurological DevelopmentDietary Supplement: fish oil|Dietary Supplement: folate|Dietary Supplement: fish oil + folate|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT01180933
105803105803The Importance of Periostin in Periodontal Health and DiseaseCompletedNo Results AvailablePeriodontal Disease|Non-diseased Patientshttps://ClinicalTrials.gov/show/NCT01180920
105804105804The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory DiseasesCompletedNo Results AvailableCancer|Inflammationhttps://ClinicalTrials.gov/show/NCT01180907
105805105805IV Iron for the Anemia of Traumatic Critical IllnessCompletedNo Results AvailableTrauma|ICU AnemiaDrug: Iron sucrose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01180894
105806105806Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation TreatmentActive, not recruitingNo Results AvailableBrain Tumor|Central Nervous System Neoplasmshttps://ClinicalTrials.gov/show/NCT01180881
105807105807The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory DiseasesCompletedNo Results AvailableAutoimmune Diseases|Cancerhttps://ClinicalTrials.gov/show/NCT01180868
105808105808Effects of Ramelteon (8mg) Alone and in Combination With Multi-Component Behavioral Therapy on Sleep and Circadian Phase in Patients With Chronic InsomniaActive, not recruitingNo Results AvailableInsomniaDrug: Placebo|Drug: Rozerem 8mg|Other: Rozerem 8mg in combination with Multi Component Behavior Therapyhttps://ClinicalTrials.gov/show/NCT01180855
105809105809Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)CompletedNo Results AvailableCystic FibrosisOther: Yoga treatment programhttps://ClinicalTrials.gov/show/NCT01180842
105810105810Pilot Study of Text Message Brief Interventions for Problem DrinkersCompletedNo Results AvailableAlcohol DependenceBehavioral: Personalized feedback text messages|Behavioral: Consciousness raising text messageshttps://ClinicalTrials.gov/show/NCT01180829

* Görseller ve İçerik tekif hakkına sahip olabilir